DELCATH SYSTEMS INC (DCTH)       3.34  +0.44 (+15.17%)

3.34  +0.44 (+15.17%)

US24661P8077 - Common Stock


Fundamental Rating

2

Overall DCTH gets a fundamental rating of 2 out of 10. We evaluated DCTH against 221 industry peers in the Health Care Equipment & Supplies industry. DCTH has a bad profitability rating. Also its financial health evaluation is rather negative. DCTH shows excellent growth, but is valued quite expensive already.




Profitability

Profitability Rating

1

DCTH has negative profitability rations, so we won't be analyzing them here.
DCTH has a Return On Assets of -156.79%. This is below the industry average of -19.67%. 96% of the industry peers outperform DCTH.

DCTH's Profit Margin of -757.03% is worse than the rest of the industry. The industry average Profit Margin is -30.04%. 87% of the industry peers have a better Profit Margin.
DCTH has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of DCTH.
VS Industry

ROA (-156.79%) VS Industry: 4% outperformed.

-771.54
117.69

Profit Margin (-757.03%) VS Industry: 13% outperformed.

-142,068.42
1,450.19

Valuation

Valuation Rating

0

DCTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year DCTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry

Growth

Growth Rating

7

The Revenue has grown by 113.94% in the past year. This is a very strong growth!
DCTH shows quite a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 12.30% yearly.
The Revenue is expected to grow by 167.95% on average over the next 5 years. This is a very strong growth

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The earnings per share for DCTH have decreased by -7.06% in the last year.
DCTH is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 7.58% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -7.06% -2.51% 18.5% 20.39% 7.58%
Revenue12.3% 1.4% 113.94% 42.86% 174.22% 173.52% 167.95%

Health

Health Rating

1

A Current Ratio of 1.28 indicates that DCTH should not have too much problems paying its short term obligations.
A Quick Ratio of 1.15 indicates that DCTH should not have too much problems paying its short term obligations.
Compared to an average industry Current Ratio of 3.69, DCTH is worse placed to pay its short term obligations than its industry peers. 90% of its industry peers have a better Current Ratio.
When comparing the Quick Ratio of DCTH to the average industry Current Ratio of 2.91, DCTH is less able to pay its short term obligations than its industry peers. 86% of its industry peers have a better Quick Ratio.

The Debt to Equity ratio of DCTH is negative (-1.85). This means it has negative shareholder equity as the company's liabilities exceed its assets. This could be considered a sign of high risk.
DCTH has an Altman-Z score of -34.64. This is a bad value and indicates that DCTH is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of DCTH to the average industry Altman-Z score of 1.89, DCTH is less financially healthy than its industry peers. 99% of its industry peers have a better Altman-Z score.
The Piotroski-F score of DCTH is 3.00. This is a low score and indicates issues in the health and profitability of DCTH.
VS Industry

Quick Ratio (1.15) VS Industry: 14% outperformed.

0.06
31.22

Current Ratio (1.28) VS Industry: 10% outperformed.

0.13
31.22

Altman-Z (-34.64) VS Industry: 1% outperformed.

-105.06
72.93

Dividend

Dividend Rating

0

No dividends for DCTH!.

DCTH Daily chart

DELCATH SYSTEMS INC3.34

NASDAQ:DCTH (12/8/2022, 3:30:01 PM)+0.44 (+15.17%)

Chartmill FA Rating
GICS Sector Health Care
GICS IndustryGroup Health Care Equipment & Services
GICS Industry Health Care Equipment & Supplies
Earnings (Last) 11-08 2022-11-08/bmo Earnings (Next) 03-23 2023-03-23
Ins Owners 6.68% Inst Owners 14.16%
Market Cap 28.72M Analysts 85.45
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 6.86 P/B N/A
EV/EBITDA -1.11
Dividend
Dividend Yield N/A Dividend Growth N/A
DP 0% Ex-Date N/A
Growth
EPS 1Y -7.06% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 2.13%
EPS Next Y -2.51% EPS Next 2Y 18.5%
EPS Next 3Y 20.39% EPS Next 5Y 7.58%
Revenue growth 1Y 113.94% Revenue growth 3Y 1.4%
Revenue growth 5Y 12.3% Revenue growth Q2Q 73.56%
Revenue Next Year 42.86% Revenue Next 2Y 174.22%
Revenue Next 3Y 173.52% Revenue Next 5Y 167.95%
Health
Current Ratio 1.28 Quick Ratio 1.15
Altman-Z -34.64 F-Score 3
Debt/Equity -1.85 WACC 9.86%
ROIC/WACC N/A
Profitability
ROA -156.79% ROE N/A
ROICexgc N/A ROIC N/A
PM -757.03% OM -691.93%
Asset Turnover 0.21

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA